<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03104322</url>
  </required_header>
  <id_info>
    <org_study_id>IPF patientMpower 02</org_study_id>
    <nct_id>NCT03104322</nct_id>
  </id_info>
  <brief_title>Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis</brief_title>
  <official_title>A Randomised, Crossover Study of Self-monitoring of Symptoms and Spirometry Via the patientMpower Platform in Patients With Idiopathic Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>patientMpower Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Health Service Executive, Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>patientMpower Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pilot-scale, open-label, fixed-order, two-period crossover study in idiopathic pulmonary
      fibrosis (IPF) over 16 weeks. Patients will use an electronic health journal (patientMpower
      platform) to record treatment compliance, forced vital capacity (FVC; daily), impact of IPF
      on daily life (weekly) and other symptoms. Objectives are to characterise acceptability of
      patientMpower platform from patient &amp; healthcare professional perspective, impact of active
      engagement and self-monitoring using patientMpower platform on Patient Reported Outcome
      Measures (PROMs) in IPF, impact of patientMpower platform on medication compliance and
      correlation between patient-reported PROMs &amp; FVC and clinical outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2017</start_date>
  <completion_date type="Actual">March 9, 2018</completion_date>
  <primary_completion_date type="Actual">March 9, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Fixed-order, two-period crossover (2 x 8 weeks), no washout, usual care controlled</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptability of patientMpower Platform From Patient &amp; Healthcare Professional Perspective</measure>
    <time_frame>single measurement at 8 weeks</time_frame>
    <description>Questionnaire-based assessment of response to questions: [pMp = patientMpower platform]
instructions for using pMp were clear
pMp helped me take the correct dose medicines
pMp helped me to take my medicines at the correct time
pMp helped me to reach my personal exercise goal
pMp helped me to walk further
pMp gave me a greater sense of control
useful to be able to record the impact of lung fibrosis on QoL
pMp encouraged me to look at the informational videos
preference for using pMp
difficulty in using pMp
effect of pMp on impact on daily life
tiring/irritating to use pMp
want to continue using pMp after study
would recommend pMp to others Possible responses Q1-8, Q12: strongly agree/agree/disagree/strongly disagree Q9: yes/no preference/no Q10: very easy/easy/difficult/very difficult Q11: positive/negative/open text Q13,14: yes/no</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medication Compliance (Days Medication Taken/Observation Period Days)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Compliance recorded by patient via patientMpower platform daily</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Idiopathic Pulmonary Fibrosis Patient Reported Outcome Measure (IPF-PROM)</measure>
    <time_frame>Baseline visit</time_frame>
    <description>12-item questionnaire with 4 domains (psychological experience of dyspnoea, physical experience of dyspnoea, emotional well-being, energy levels). 3 questions/domain asking frequency of symptom or its impact in the time interval since last response. Four possible responses to each question: none of the time/some of the time/most of the time/all of the time. Numerical score assigned to each response 1/2/3/4 (respectively). Impact on domain characterised by mean score for each of 3 questions in that domain. One question on overall quality of life with responses: excellent/good/fair/poor/very poor. Numerical score assigned to each response 1/2/3/4/5 respectively. Low score better outcome; high score worse outcome (for all responses).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Exercise Performance</measure>
    <time_frame>8 weeks</time_frame>
    <description>Activity (steps/day) recorded via FitBit or patient's phone and transmitted to patientMpower platform</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Forced Vital Capacity (FVC)</measure>
    <time_frame>8 weeks</time_frame>
    <description>Forced vital capacity recorded via patientMpower platform daily</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>Observation sequence</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>patientMpower platform</intervention_name>
    <description>electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms</description>
    <arm_group_label>Observation sequence</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual care</intervention_name>
    <description>usual care</description>
    <arm_group_label>Observation sequence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  confirmed diagnosis of idiopathic pulmonary fibrosis (IPF).

          -  daily unrestricted access to smartphone or tablet device at home.

          -  demonstrated understanding of protocol and correct use of Spirobank Smart spirometer
             and patientMpower platform.

          -  able and willing to perform spirometry every day at home.

          -  willing to give written informed consent

        Exclusion Criteria:

          -  significant confusion or any concomitant medical condition which would limit the
             ability of the patient to record symptoms or use a home spirometer on a regular basis.

          -  new prescription of antifibrotic therapy for IPF (e.g. pirfenidone, nintedanib) within
             4 weeks before baseline visit.

          -  recent exacerbation of IPF or other clinically significant change in the patient's
             medical condition in 4 weeks before baseline visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dept. of Respiratory Medicine</last_name>
    <role>Principal Investigator</role>
    <affiliation>Galway University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Respiratory Medicine</name>
      <address>
        <city>Galway</city>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <link>
    <url>https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A4933</url>
    <description>American Thoracic Society 2018 poster abstract</description>
  </link>
  <reference>
    <citation>S. Walsh, T. Cahill, C. Edwards, E. Costello, J. Walsh, A.-M. Russell, A.W. O'Regan. Patient-Reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 2018;197: A4933</citation>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 27, 2017</study_first_submitted>
  <study_first_submitted_qc>March 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2017</study_first_posted>
  <results_first_submitted>August 1, 2018</results_first_submitted>
  <results_first_submitted_qc>January 21, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 23, 2019</results_first_posted>
  <last_update_submitted>March 19, 2019</last_update_submitted>
  <last_update_submitted_qc>March 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>digital health</keyword>
  <keyword>home spirometry</keyword>
  <keyword>patient reported outcome measure</keyword>
  <keyword>e-health</keyword>
  <keyword>pirfenidone</keyword>
  <keyword>nintedanib</keyword>
  <keyword>FVC</keyword>
  <keyword>antifibrotic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 12, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/22/NCT03104322/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Observation Sequence</title>
          <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks
patientMpower platform: electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms
usual care: usual care</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Observation Sequence</title>
          <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks
patientMpower platform: electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms
usual care: usual care</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69" lower_limit="57" upper_limit="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>white</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Ireland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Acceptability of patientMpower Platform From Patient &amp; Healthcare Professional Perspective</title>
        <description>Questionnaire-based assessment of response to questions: [pMp = patientMpower platform]
instructions for using pMp were clear
pMp helped me take the correct dose medicines
pMp helped me to take my medicines at the correct time
pMp helped me to reach my personal exercise goal
pMp helped me to walk further
pMp gave me a greater sense of control
useful to be able to record the impact of lung fibrosis on QoL
pMp encouraged me to look at the informational videos
preference for using pMp
difficulty in using pMp
effect of pMp on impact on daily life
tiring/irritating to use pMp
want to continue using pMp after study
would recommend pMp to others Possible responses Q1-8, Q12: strongly agree/agree/disagree/strongly disagree Q9: yes/no preference/no Q10: very easy/easy/difficult/very difficult Q11: positive/negative/open text Q13,14: yes/no</description>
        <time_frame>single measurement at 8 weeks</time_frame>
        <population>Patients who completed study and provided response to questionnaire</population>
        <group_list>
          <group group_id="O1">
            <title>Observation Sequence</title>
            <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks
patientMpower platform: electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms
usual care: usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Acceptability of patientMpower Platform From Patient &amp; Healthcare Professional Perspective</title>
          <description>Questionnaire-based assessment of response to questions: [pMp = patientMpower platform]
instructions for using pMp were clear
pMp helped me take the correct dose medicines
pMp helped me to take my medicines at the correct time
pMp helped me to reach my personal exercise goal
pMp helped me to walk further
pMp gave me a greater sense of control
useful to be able to record the impact of lung fibrosis on QoL
pMp encouraged me to look at the informational videos
preference for using pMp
difficulty in using pMp
effect of pMp on impact on daily life
tiring/irritating to use pMp
want to continue using pMp after study
would recommend pMp to others Possible responses Q1-8, Q12: strongly agree/agree/disagree/strongly disagree Q9: yes/no preference/no Q10: very easy/easy/difficult/very difficult Q11: positive/negative/open text Q13,14: yes/no</description>
          <population>Patients who completed study and provided response to questionnaire</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>agree instructions clear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>agree helped correct dose of meds</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>agree helped time of meds</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>agree motivated re exercise</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>agree helped walk further</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>agree gave greater sense control</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>agree useful record impact on QoL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>agree helped look at information videos</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>prefer using patientMpower</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>easy to use patientMpower</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>positive effect on impact on daily life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>agree tiring/irritating to use patientMpower</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>want to continue after end study</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>would recommend to others</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Medication Compliance (Days Medication Taken/Observation Period Days)</title>
        <description>Compliance recorded by patient via patientMpower platform daily</description>
        <time_frame>8 weeks</time_frame>
        <population>Patients did not record medication compliance during study timeframe.</population>
        <group_list>
          <group group_id="O1">
            <title>Observation Sequence</title>
            <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks
patientMpower platform: electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms
usual care: usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Compliance (Days Medication Taken/Observation Period Days)</title>
          <description>Compliance recorded by patient via patientMpower platform daily</description>
          <population>Patients did not record medication compliance during study timeframe.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Idiopathic Pulmonary Fibrosis Patient Reported Outcome Measure (IPF-PROM)</title>
        <description>12-item questionnaire with 4 domains (psychological experience of dyspnoea, physical experience of dyspnoea, emotional well-being, energy levels). 3 questions/domain asking frequency of symptom or its impact in the time interval since last response. Four possible responses to each question: none of the time/some of the time/most of the time/all of the time. Numerical score assigned to each response 1/2/3/4 (respectively). Impact on domain characterised by mean score for each of 3 questions in that domain. One question on overall quality of life with responses: excellent/good/fair/poor/very poor. Numerical score assigned to each response 1/2/3/4/5 respectively. Low score better outcome; high score worse outcome (for all responses).</description>
        <time_frame>Baseline visit</time_frame>
        <population>patients who provided at least 1 IPF-PROM; insufficient data for analysis of time trends; Baseline values reported</population>
        <group_list>
          <group group_id="O1">
            <title>Observation Sequence</title>
            <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks
patientMpower platform: electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms
usual care: usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Idiopathic Pulmonary Fibrosis Patient Reported Outcome Measure (IPF-PROM)</title>
          <description>12-item questionnaire with 4 domains (psychological experience of dyspnoea, physical experience of dyspnoea, emotional well-being, energy levels). 3 questions/domain asking frequency of symptom or its impact in the time interval since last response. Four possible responses to each question: none of the time/some of the time/most of the time/all of the time. Numerical score assigned to each response 1/2/3/4 (respectively). Impact on domain characterised by mean score for each of 3 questions in that domain. One question on overall quality of life with responses: excellent/good/fair/poor/very poor. Numerical score assigned to each response 1/2/3/4/5 respectively. Low score better outcome; high score worse outcome (for all responses).</description>
          <population>patients who provided at least 1 IPF-PROM; insufficient data for analysis of time trends; Baseline values reported</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline overall quality of life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" lower_limit="1" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline psychological impact of dyspnoea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" lower_limit="1.3" upper_limit="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline physical impact of breathlessness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.85" lower_limit="1.0" upper_limit="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline psychological wellbeing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.35" lower_limit="1.0" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline energy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" lower_limit="1.0" upper_limit="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-reported Exercise Performance</title>
        <description>Activity (steps/day) recorded via FitBit or patient's phone and transmitted to patientMpower platform</description>
        <time_frame>8 weeks</time_frame>
        <population>No data available for analysis due to technical issues (no patient used a FitBit or mobile device with built-in accelerometer)</population>
        <group_list>
          <group group_id="O1">
            <title>Observation Sequence</title>
            <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks
patientMpower platform: electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms
usual care: usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-reported Exercise Performance</title>
          <description>Activity (steps/day) recorded via FitBit or patient's phone and transmitted to patientMpower platform</description>
          <population>No data available for analysis due to technical issues (no patient used a FitBit or mobile device with built-in accelerometer)</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient-reported Forced Vital Capacity (FVC)</title>
        <description>Forced vital capacity recorded via patientMpower platform daily</description>
        <time_frame>8 weeks</time_frame>
        <population>All entered patients who provided home spirometry data</population>
        <group_list>
          <group group_id="O1">
            <title>Observation Sequence</title>
            <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks
patientMpower platform: electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms
usual care: usual care</description>
          </group>
        </group_list>
        <measure>
          <title>Patient-reported Forced Vital Capacity (FVC)</title>
          <description>Forced vital capacity recorded via patientMpower platform daily</description>
          <population>All entered patients who provided home spirometry data</population>
          <units>L</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline FVC (patient-reported)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.40" lower_limit="1.51" upper_limit="3.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8-week FVC (patient-reported)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" lower_limit="2.2" upper_limit="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>16 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Observation Sequence</title>
          <description>Period 1: patientMpower platform+usual care for 8 weeks; Period 2: usual care alone for 8 weeks
patientMpower platform: electronic health journal for patient to record compliance, spirometry, impact on daily life and symptoms
usual care: usual care</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chief Scientific Officer</name_or_title>
      <organization>patientMpower</organization>
      <phone>+353872599131</phone>
      <email>colin@patientmpower.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

